The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results–Medicare Data
Open accessAbstract
Purpose: Recent studies have reported increased mortality for right-sided colon cancers but had limited adjustment for patient characteristics and conflicting results by stage. We examined the relationship between colon cancer location (right- v left-side) and 5-year mortality by stage. Patients and Methods: We identified Medicare beneficiaries from 1992 to 2005 with American Joint Commission on Cancer stages I to III primary adenocarcinoma of the colon who underwent surgery for curative intent through Surveillance, Epidemiology, and End Results (SEER) –Medicare data. Adjusted hazard ratios (HRs) and 95% CIs for predictors of all-cause 5-year mortality were obtained by using Cox proportional hazards regression. Results: Of 53,801 patients, 67% had right-sided colon cancer. Patients with right-sided cancer were more likely to be older, to be women, to be diagnosed with a more advanced stage, and to have more poorly differentiated tumors. Adjusted Cox regression showed no significant difference in mortality between right- and left-sided cancers for all stages combined (HR, 1.01; 95% CI, 0.98 to 1.04; P = .598) or for stage I cancers (HR, 0.95; 95% CI, 0.88 to 1.03; P = .211). Stage II right-sided cancers had lower mortality than left-sided cancers (HR, 0.92; 95% CI, 0.87 to 0.97; P = .001), and stage III right-sided cancers had higher mortality (HR, 1.12; 95% CI, 1.06 to 1.18; P < .001). Conclusion: When analysis was adjusted for multiple patient, disease, comorbidity, and treatment variables, no overall difference in 5-year mortality was seen between right- and left-sided colon cancers. However, within stage II disease, right-sided cancers had lower mortality; within stage III, right-sided cancers had higher mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., & Riley, G. F. (2002) · PubMed · doi:10.1097/01.mlr.0000020942.47004.03 · Cited by 1,714
Benson, A. B., Schrag, D., Somerfield, M. R., Cohen, A. M., Figueredo, A. T., Flynn, P. J., Krzyzanowska, M. K., Maroun, J., McAllister, P., Van Cutsem, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.063 · Cited by 1,430
Are there two sides to colorectal cancer?
Iacopetta, B. (2002) · International Journal of Cancer · doi:10.1002/ijc.10635 · Cited by 782
Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., & Riley, G. F. (2002) · Medical Care · doi:10.1097/00005650-200208001-00002 · Cited by 772
Bufill, J. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-10-779 · Cited by 722
Benedix, F., Kube, R., Meyer, F., Schmidt, U., Gastinger, I., & Lippert, H. (2010) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181c703a4 · Cited by 713
POTOSKY, A. L., RILEY, G. F., LUBITZ, J. D., MENTNECH, R. M., & KESSLER, L. G. (1993) · Medical Care · doi:10.1097/00005650-199308000-00006 · Cited by 694
Is There a Difference in Survival between Right- versus Left-Sided Colon Cancers?
Meguid, R. A., Slidell, M. B., Wolfgang, C. L., Chang, D. C., & Ahuja, N. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0015-y · Cited by 546
(2012) · Hepatogastroenterology · doi:10.5754/hge10856 · Cited by 531
Samowitz, W. S., Curtin, K., Ma, K., Schaffer, D., Coleman, L. W., Leppert, M., & Slattery, M. L. (2001) · PubMed · Cited by 401
Hemminki, A., Mecklin, J., Järvinen, H., Aaltonen, L. A., & Joensuu, H. (2000) · Gastroenterology · doi:10.1053/gast.2000.18161 · Cited by 352
Two colons‐two cancers: Paradigm shift and clinical implications
Gervaz, P., Bucher, P., & Morel, P. (2004) · Journal of Surgical Oncology · doi:10.1002/jso.20156 · Cited by 302
Using diagnoses to describe populations and predict costs.
Ash, A. S., Ellis, R. P., Pope, G. C., Ayanian, J. Z., Bates, D. W., Burstin, H. R., Iezzoni, L. I., MacKay, E., & Yu, W. (2000) · PubMed Central · Cited by 299
Distinguishing right from left colon by the pattern of gene expression.
Glebov, O. K., Rodriguez, L. M., Nakahara, K., Jenkins, J., Cliatt, J., Humbyrd, C. J., DeNobile, J. W., Soballe, P. W., Simon, R., Wright, G. W., et al. (2003) · PubMed · Cited by 279
Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer
Malesci, A., Laghi, L., Bianchi, P., Delconte, G., Randolph, A., Torri, V., Carnaghi, C., Doci, R., Rosati, R., Montorsi, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0366 · Cited by 245
Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid
Birkenkamp-Demtroder, K., Olesen, S. H., Sørensen, F. B., Laurberg, S., Laiho, P., Aaltonen, L. A., & Ørntoft, T. F. (2005) · Gut · doi:10.1136/gut.2003.036848 · Cited by 242
Continued Rightward Shift of Colorectal Cancer
Cucino, C., Buchner, A. M., & Sonnenberg, A. (2002) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6356-0 · Cited by 160
Saltzstein, S. L., & Behling, C. A. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225550.26751.6a · Cited by 113
Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers
Jernvall, P., Mäkinen, M. J., Karttunen, T. J., Mäkelä, J. T., & Vihko, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00306-2 · Cited by 105
Outcomes in Older People Undergoing Operative Intervention for Colorectal Cancer
Patel, S. A., & Zenilman, M. E. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.4911254.x · Cited by 41
Cited by
Colorectal cancer liver metastases – a population-based study on incidence, management and survival
Engstrand, J., Nilsson, H., Strömberg, C., Jonas, E., & Freedman, J. (2018) · BMC Cancer · doi:10.1186/s12885-017-3925-x · Cited by 896
Petrelli, F., Tomasello, G., Borgonovo, K., Ghidini, M., Turati, L., Dallera, P., Passalacqua, R., Sgroi, G., & Barni, S. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.4227 · Cited by 729
From tumour heterogeneity to advances in precision treatment of colorectal cancer
Punt, C. J. A., Koopman, M., & Vermeulen, L. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.171 · Cited by 654
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
Missiaglia, E., Jacobs, B., D'Ario, G., Di Narzo, A. F., Soneson, C., Budinska, E., Popovici, V., Vecchione, L., Gerster, S., Yan, P., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu275 · Cited by 646
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
Loupakis, F., Yang, D., Yau, L., Feng, S., Cremolini, C., Zhang, W., Maus, M. K. H., Antoniotti, C., Langer, C., Scherer, S. J., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju427 · Cited by 472
Metadata
- Authors
- Weiss, J. M., Pfau, P. R., O'Connor, E. S., King, J., LoConte, N., Kennedy, G., & Smith, M. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-11-20
- Volume
- 29
- Issue
- 33
- Pages
- 4401-4409
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2118210036
- Cited by
- 412
- References
- 24
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.